Cite

HARVARD Citation

    Fujita, T. et al. (2019). Pembrolizumab‐induced interstitial lung disease following thoracic surgery in a patient with non‐small cell lung cancer. Thoracic cancer. 10 (11), pp. 2179-2182. [Online]. 
  
Back to record